Sam Lidman: Daily

From staid SaaS to a Bitcoin Cash treasury, mF International has remade itself. We look beneath the surface of its radical reinvention and ask: is this genius or a gamble?

With the launch of Cloud Aurora, Ariana Grande isn't just dropping a new perfume. She's reinforcing a masterclass in building a permanent, resilient brand.

Almadex Minerals' $500K sale of its El Cobre royalty is more than a minor transaction; it's a calculated move to fund its US exploration pipeline.

With a new FDA Fast Track designation, Satellos Bioscience aims to accelerate its unique muscle-regenerating drug for Duchenne, a strategy that could sidestep genetic limitations.

Ring Energy's entry into the Russell 3000 is more than a milestone; it's a testament to strategic discipline. What does this reveal about value creation?

The #HMC2026 conference revealed a Malaysian hospitality sector in deep recalibration, moving beyond old playbooks to forge resilience for its next growth era.

As The Baldwin Group preps its Q2 results, all eyes are on its strategy. Will the call reveal a path to resilience or a prelude to a private equity sale?

As rising property values outpace federal coverage, Neptune Flood's new $15M limit signals a pivotal shift in how America protects its most valuable assets.

Wise's stellar FY26 results show more than just growth. They reveal a durable strategy of infrastructure, regulation, and customer value in a volatile market.

The PFRPA Champions Banquet in Atlanta honors local legends, revealing a powerful new playbook for how former athletes construct legacies of permanence.

Cap's integration with Franklin Templeton's BENJI fund is more than a partnership; it's a blueprint for how traditional finance will adopt and legitimize DeFi.

Beyond the specs, Sunwoda's new ESS platform reveals a masterclass in navigating global energy markets through technical superiority and regulatory foresight.

Dr. Glenda Glover's new book exposes a $2.1B underfunding of TSU, sparking a national debate on the resilience and financial future of America's HBCUs.

Beyond a simple tech deal, Aritzia's partnership with Adyen reveals a masterclass in building permanence by unifying its luxury brand experience.

Hitting $2M ARR, VMEG AI challenges the 'black box' status quo, offering enterprises transparent control over global video localization and brand integrity.

Lycia Therapeutics' oversubscribed $75M Series D validates its unique LYTAC platform, which aims to treat autoimmune diseases by destroying harmful proteins.

Professor Jason Chin’s Heinrich Wieland Prize signals a new era. His work in synthetic biology is enabling Constructive Bio to forge a new class of drugs.

Verano's upcoming Q2 report is a key indicator for the cannabis sector. We look at the strategic moves, from stock splits to rescheduling, setting the stage.

Dubai is making a calculated play in Berlin, using GITEX AI Europe not just to showcase its tech but to architect a resilient, high-performance digital future.

Kadima Neuropsychiatry sues NRx Pharma, alleging deceit in a failed acquisition. The case reveals the high stakes of corporate integrity and financial truth.